Stage
No active trials
Next date
None yet
Trials
0 active
4 in total
Targets
—
None known yet
What this is
- How it works
- A cell therapy: living cells given to the patient as the treatment.-cel: cell therapies WHO name stem
- How it’s given
- “On Day 14, 20 intramuscular injections of ixmyelocel-T on pre-identified index leg.”In the company’s words, NCT01483898 on ClinicalTrials.gov
- Tested for
- Dilated Cardiomyopathy (2 trials), Critical Limb Ischemia, Ischemic Dilated Cardiomyopathy (IDCM)
- Main trialPhase 3
- “This study is designed to evaluate the efficacy and safety of ixmyelocel-T, a patient-specific expanded multicellular therapy, for the treatment of patients with critical limb ischemia (CLI). The study is a randomized, vehicle controlled (placebo)study in CLI patients who have no option for revascularization procedures. All patients randomized will undergo a small volume bone marrow aspiration in a 15-minute outpatient or in-office procedure. All patients will receive injections of either ixmyelocel-T or vehicle-control into their pre-identified index leg. Patients will be followed for 18…”In the company’s words, NCT01483898 on ClinicalTrials.gov
Other drugs for Dilated Cardiomyopathy
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 25 Mar 2014 | An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) | |
| Phase 2Completed | 11 Jan 2012 | Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy | |
| Phase 2Completed | 5 Sep 2012 | Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM) | |
| Phase 2Completed | 1 Feb 2016 | An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026